Brought to you by 
TransPharma completes $18mm Series C round
17 Aug 2006
Executive Summary
Israeli drug delivery company TransPharma Medical (TPM) has completed its Series C round, raising $18mm. Argonaut Private Equity led the financing that included new investor Teva Pharmaceutical Industries, TPM's partner for marketing the ViaDerma transdermal delivery system and developing up to five drug candidates. Returning backers Pitango Venture Capital, Evergreen Partners, T2C2/Bio, Vitalife, Biomedical Investments, and TIF Ventures Pte Ltd. also participated. A member of Argonaut will join TPM's board.
Deal Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
TransPharma completes $18mm Series C round
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice